Drugmakers Bulk Up With Bets on Weight Loss Treatments Drugmakers Bulk Up With Bets on Weight Loss Treatments
Zealand Pharma and partner Boehringer Ingelheim on Wednesday announced positive trial data for their weight-loss treatment and joined the race for a share of a global obesity drug market that is expected to touch $100 billion within a decade.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
More News: Diabetes | Eating Disorders & Weight Management | Endocrinology | Health | New Zealand Health | Obesity | Pharmaceuticals | Weight Loss